• U0126: Selective MEK1/2 Inhibitor Guide

  2026-09-04

  U0126 is a non-ATP-competitive MEK1/2 inhibitor that suppresses ERK1/2 phosphorylation and supports mechanistic studies of MAPK signaling. Its defined nanomolar kinase benchmarks, cell permeability, and reported effects on autophagy and mitophagy make it useful across cancer biology research and neurobiology, subject to assay-specific validation.

• Diminazene Aceturate: Applied Research Workflows

  2026-09-03

  Diminazene Aceturate supports two distinct research paths: trypanocidal experiments in parasite systems and pharmacological ACE2 activation studies linked to cardiac mitochondrial biology. This practical guide covers formulation, assay design, controls, optimization, and the limitations of translating findings between these domains.

• Naftifine HCl for Antifungal Assay Design

  2026-09-03

  Naftifine HCl provides a practical, mechanism-led tool for sterol-biosynthesis studies, fungal growth assays, and orthogonal control design. This guide connects its allylamine antifungal activity with disciplined workflows inspired by WNT5a/GSK3/β-catenin research while clearly separating validated antifungal applications from exploratory muscle-cell experiments.

• Z-YVAD-FMK in HOXC8-Driven Pyroptosis Research

  2026-09-02

  Explore how the caspase-1 inhibitor Z-YVAD-FMK can clarify the HOXC8–CASP1–GSDMD axis in lung cancer. This mechanistic guide explains assay design, controls, dosing logic, and the limits of interpreting pyroptosis inhibition.

• EdU Imaging Kits (HF594) for Resistance Studies

  2026-09-02

  EdU Imaging Kits (HF594) transform DNA synthesis measurement into a decision-ready readout for gefitinib-resistant adenocarcinoma models. This article explains how click chemistry, dual-platform imaging, and careful endpoint interpretation can strengthen studies of PI3K–AKT–ERK blockade and nanomedicine.

• Viral RIPK3 Degradation and Inflammation

  2026-09-01

  Liu and colleagues identified a conserved orthopoxvirus factor that recruits host SCF machinery to promote RIPK3 ubiquitination and proteasomal degradation. Their genetic, biochemical, virological, and mouse experiments show that this viral inducer of RIPK3 degradation reshapes necroptosis, inflammation, viral replication, and pathogen–host adaptation.

• Mitochondrial Calcium Signaling Represses Ferroptosis

  2026-09-01

  The reference study identifies mitochondrial calcium uptake through MCU as an upstream regulator of GPX4 activity and ferroptosis resistance. Its combination of mouse genetics, antioxidant rescue, GPX4 mutagenesis, and structural analysis suggests that calcium-dependent acetyl-CoA metabolism sustains GPX4 function and influences tumor growth.

• YM-155 Hydrochloride: Assay Workflow Guide

  2026-08-31

  Build more informative survivin inhibitor experiments by pairing proliferation measurements with direct cell-death endpoints. This workflow shows how YM-155 hydrochloride can support apoptosis inhibitor research, concentration–response profiling, and better interpretation of cancer-cell drug responses.

• JSH-23: A Practical NF-κB Inhibitor Workflow

  2026-08-31

  JSH-23 enables pathway-positioned inflammation research by blocking NF-κB p65 nuclear localization and DNA binding without preventing IκB degradation. This guide translates that distinction into cell-based assays, reference-informed macrophage studies, and a cisplatin-induced acute kidney injury model workflow.

• Lovastatin Workflow for HMG-CoA Reductase Assays

  2026-08-30

  Build more interpretable cholesterol-metabolism experiments with Lovastatin, from dose–response screening to macrophage efferocytosis and fibroblast apoptosis workflows. This guide combines practical formulation advice with a plant-development study that illustrates how orthogonal pathway and phenotype readouts can strengthen mechanism-focused research.

• Tropifexor: Dissecting FXR and Nutrient Signals

  2026-08-29

  Tropifexor (LJN452) offers a precise way to separate FXR-driven epithelial responses from nutrient-derived hepatic signaling. This article uses triacetin absorption research to build a more rigorous experimental framework for intestinal barrier and metabolic disease studies.

• Ellagic acid: A Rigorous CK2 Assay Strategy

  2026-08-28

  Ellagic acid is a selective CK2 probe with applications spanning cancer biology research, oxidative stress assays, and apoptosis studies. This guide develops a senescence-aware validation framework that distinguishes target engagement from downstream phenotype and avoids overinterpreting machine-learning-derived senolytic findings.

• Dasatinib Monohydrate: Mechanism and Research Use

  2026-08-28

  Dasatinib Monohydrate (BMS-354825) is an ATP-competitive, multitargeted tyrosine kinase inhibitor with activity against BCR-ABL, SRC, KIT, and PDGFR. Its strongest research rationale is imatinib-resistant BCR-ABL inhibition in CML and Ph-positive acute lymphoblastic leukemia, while patient-derived assembloids offer a complementary framework for studying stromal effects on drug response.

• Mitochondrial Calcium Signaling Represses Ferroptosis

  2026-08-27

  The reference study identifies a mechanistic connection between mitochondrial calcium uptake through MCU and GPX4 activity, showing that calcium-dependent acetyl-CoA production supports GPX4 acetylation and ferroptosis suppression. Its combination of genetic, structural, mutational, animal, and cancer-model evidence provides a framework for interpreting mitochondrial metabolism in ferroptosis assays and tumor biology.

• Liproxstatin-1 HCl: Reliable Ferroptosis Assays

  2026-08-27

  This scenario-based guide shows how Liproxstatin-1 HCl (SKU B8221) can improve interpretation of viability, cytotoxicity, and ferroptosis experiments through pathway-selective rescue, practical formulation guidance, and appropriate controls. It connects product data with mechanistic evidence while emphasizing reproducible assay design and cautious data interpretation.

8438 records 2/563 page Previous Next 12345 下5页 Last page